MOX-5

........10........20........30........40........50........60........70........80........90.......100.......110.......120.......130.......140.......150.......160.......170.......180.......190.......200.......210.......220.......230.......240.......250.......260.......270.......280.......290.......300.......310.......320.......330.......340.......350.......360.......370.......380... MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSRGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLNVPEQPMGHYAYGYWKEDKPFRVTPAMLAEEPYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYPYPVSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFKKTGSTNGFGAYVAFVPAKGIGVVMLANRNYPNEGTLKAGHAILTQLAR

MOX-6	..........V.P............R...............................................................................S.................V...........................................P.................................I................A........S.....I....G...D.A....................................................A.............A...............R......N.....................I.......S.I................	94.78 %
MOX-7	....................V....................................................................................S.................V...........................................P.............................................T....A........S.....I....G...D.A..................G.................................A....................I..V............N.....................I.......S.I.ARI..A.........	93.99 %
MOX-12	.......................................................................................................................................................................P.................................I................A........S.....I....G...D.A....................................................A...................T................N.................................ARI..A.....K...	95.82 %
MOX-13	.................................................L.......................................................S...........S.................................................P.................................I................A........S.....I....G...D.A....................................................A.............................T......N.....................I...........ARI..A.........	95.04 %
MOX-15	.......................................................................................................................................................................P.................................I...........T....A........S.....I....G...D.A....................................................A.............................T......N.....................I...........ARI..A.....K...	95.30 %

Last updated: January 08, 2024.

If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.

The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).

Contact: contact@bldb.eu

Live statistics (since December 3rd, 2023)